Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
2.
Cutis ; 110(2): 105-108, 2022 Aug.
Article in English | MEDLINE | ID: mdl-36219645

ABSTRACT

Alopecia areata (AA) is an autoimmune disorder characterized by well-demarcated patches of hair loss with preservation of the hair follicle (HF). It generally is a nonscarring alopecia that can be extensive and refractory to treatment. We propose modification to an already widely used first-line treatment by diluting intralesional triamcinolone acetonide (ILTA) to 2.5 mg/mL in 1% lidocaine and epinephrine 1:100,000 in place of normal saline (NS). Our 2 cases of severe AA are among many in our practice that responded with seemingly permanent hair regrowth using this novel combination regimen. We hypothesize that local vasoconstriction due to epinephrine potentiates the ILTA and that epinephrine also may play an independent role.


Subject(s)
Alopecia Areata , Alopecia Areata/drug therapy , Epinephrine , Humans , Lidocaine , Saline Solution , Triamcinolone Acetonide
4.
Dermatol Pract Concept ; 11(1): e2021126, 2021 Jan.
Article in English | MEDLINE | ID: mdl-33614211

ABSTRACT

Dermatologic procedures are performed under varying degrees of antisepsis, and no clear guidelines exist regarding the role of the aseptic technique in dermatology. This review aims to clarify the terminology surrounding surgical asepsis and examines the importance of various components of the aseptic technique in cutaneous surgery. Included are studies examining optimal glove type, surgical instruments, skin antisepsis, and cost-reducing protocols. Our review highlights that most dermatology procedures are not performed under completely sterile conditions due to the lack of environmental and foot traffic controls in dermatology offices. In addition, for some outpatient procedures, such as for minor excisions and Mohs surgery before reconstruction, elements of the clean technique can be used without increasing infection rates. However, data on the feasibility of a clean protocol for Mohs reconstruction is conflicting. Future prospective, randomized trials analyzing various components of the aseptic technique in dermatology are greatly needed so that guidelines can be established for practicing dermatologists.

5.
Cureus ; 12(6): e8936, 2020 Jun 30.
Article in English | MEDLINE | ID: mdl-32765982

ABSTRACT

Ichthyotherapy or fish pedicure is a unique form of biotherapy in which the species Garra rufa or doctor fish is used to exfoliate the skin and potentially aid in healing diseases, such as psoriasis. The practice has gained popularity since its origins in Kangal Fish Spring in Turkey; however, safety concerns, especially among immunocompromised patients, remain. This article reviews the studied dermatological benefits of ichthyotherapy and theorized mechanisms of action. Included are cases examining both infectious and noninfectious complications of this procedure. This review highlights the need to educate susceptible patients about possible adverse effects and the need for more studies assessing this procedure.

6.
J Drugs Dermatol ; 19(5): 471-474, 2020 May 01.
Article in English | MEDLINE | ID: mdl-32484627

ABSTRACT

Multiple primary melanomas (MPMs) have been reported to occur in 2-10% of melanoma patients. This study conducted a review of the literature to elucidate the definitions of terminology used to describe MPMs that were diagnosed in close temporal proximity as well as explore common risk factors. Terminology found in the literature included “concurrent”, “simultaneous” and “synchronous” with varying definitions that ranged from 0-6 months between diagnoses of the first and subsequent melanomas. Eight cases are described in chronological order, and the incidence of MPMs diagnosed around the same time were reported as 22-39%. Nevus spilus was identified as a potential risk factor for MPMs. This study highlights that MPMs are not uncommon, and clinicians should remain aware that MPMs can be diagnosed at or around the same time, warranting thorough skin exams. J Drugs Dermatol. 2020;19(5): doi:10.36849/JDD.2020.4953.


Subject(s)
Melanoma/diagnosis , Neoplasms, Multiple Primary/diagnosis , Skin Neoplasms/diagnosis , Terminology as Topic , Biopsy , Humans , Incidence , Melanoma/epidemiology , Melanoma/pathology , Neoplasms, Multiple Primary/epidemiology , Neoplasms, Multiple Primary/pathology , Skin/pathology , Skin Neoplasms/epidemiology , Skin Neoplasms/pathology , Survival Rate , Time Factors
8.
J Dermatolog Treat ; 31(6): 639-648, 2020 Sep.
Article in English | MEDLINE | ID: mdl-30265595

ABSTRACT

Background: Skin substitutes are designed to accelerate wound healing by providing replacement of extracellular matrix and can be used to promote healing of both acute and chronic wounds.Aim: To describe advantages, disadvantages, and indications for different skin substitutes with the intention of providing a systematic framework that clinicians can easily utilize in clinical practice.Materials and method: We conducted a PubMed, Cochrane Library, and company website search for publications using various search terms associated with skin substitutes.Results: Skin substitutes can be categorized as epidermal, dermal, and composite, depending on the skin component they contain, and further split into different categories depending on their composition and source of material, including xenograft, acellular allograft, cellular allograft, autograft, and synthetic skin substitutes. Because there is no ideal option for skin substitutes that meet all the criteria for optimal wound healing, there is ongoing research evaluating and developing different skin substitute options.Conclusion: Our model of skin substitutes was organized based on the different layers of cutaneous involvement and the origin of the product material. We believe that this framework provides a practical guide for selection of the most appropriate skin substitute based on clinical indication.


Subject(s)
Skin, Artificial , Skin/injuries , Wound Healing , Amnion/cytology , Dermis/cytology , Epidermal Cells/cytology , Humans , Skin Transplantation , Transplantation, Autologous , Transplantation, Homologous
10.
Am J Dermatopathol ; 41(8): 571-577, 2019 Aug.
Article in English | MEDLINE | ID: mdl-31335409

ABSTRACT

Endocrine mucin-producing sweat gland carcinoma (EMPSGC) and primary cutaneous mucinous carcinoma (PCMC) are both uncommon low-grade cutaneous adnexal tumors with predilection for the eyelids of elderly women. Their clinical appearance is nonspecific, typically presenting as a slowly growing poorly circumscribed papule, nodule, plaque, or swelling. Histological features of EMPSGC include a lobulated dermal neoplasm with bland cytology and an invasive mucinous component in up to half of the cases. PCMC exhibits tumor nests suspended in abundant pools of mucin with focal strands or nests of tumor cells infiltrating the dermis. Because of their rarity and banal cytological features, both entities pose a risk for misdiagnosis with other benign/malignant cutaneous adnexal neoplasms. Histomorphological features can suggest a diagnosis of EMPSGC or PCMC, but immunohistochemistry is necessary for confirmation. A review of the literature showed variable results of antigens present in EMPSGC, and many of the positive markers only show sparse or focal immunoreactivity of tumor cells. As a result, diffusely positive markers play a crucial role in identification of these tumors, particularly with initial superficial biopsies. We present 9 cases of EMPSGC and 5 cases of PCMC with strong and diffuse immunoreactivity to renal cell carcinoma antigen. This novel finding can be useful in the diagnosis of EMPSGC and PCMC in combination with other known positive markers to differentiate them from other cutaneous neoplasms. In addition, it provides further evidence that EMPSGC could be a precursor lesion to PCMC with both existing on a spectrum.


Subject(s)
Adenocarcinoma, Mucinous/chemistry , Antigens, Neoplasm/analysis , Biomarkers, Tumor/analysis , Mitogen-Activated Protein Kinases/analysis , Sweat Gland Neoplasms/chemistry , Adenocarcinoma, Mucinous/pathology , Adenocarcinoma, Mucinous/surgery , Aged , Aged, 80 and over , Female , Humans , Immunohistochemistry , Male , Middle Aged , Predictive Value of Tests , Sweat Gland Neoplasms/pathology , Sweat Gland Neoplasms/surgery
11.
Am J Clin Dermatol ; 20(3): 409-422, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30895525

ABSTRACT

Sarcoidosis is an inflammatory disease defined by the presence of non-caseating granulomas. It can affect a number of organ systems, most commonly the lungs, lymph nodes, and skin. Cutaneous manifestations of sarcoidosis can impose a significant detriment to patients' quality of life. The accepted first-line therapy for cutaneous sarcoidosis consists of intralesional and oral corticosteroids, but these can fail in the face of resistant disease and corticosteroid-induced adverse effects. Second-line agents include tetracyclines, hydroxychloroquine, and methotrexate. Biologics are an emerging treatment option for the management of cutaneous sarcoidosis, but their role in management is not well-defined. In this article, we reviewed the currently available English-language publications on the use of biologics in managing cutaneous sarcoidosis. Although somewhat limited, the data in published studies support the use of both infliximab and adalimumab as third-line treatments for chronic or resistant cutaneous sarcoidosis. There were also scattered reports of etanercept, rituximab, golimumab, and ustekinumab being utilized as third-line agents with varying degrees of success. Larger and more extensive investigations are required to further assess the adverse effect profile and optimal dosing for managing cutaneous sarcoidosis.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Biological Products/therapeutic use , Glucocorticoids/pharmacology , Sarcoidosis/drug therapy , Skin Diseases/drug therapy , Adalimumab/therapeutic use , Antibodies, Monoclonal/therapeutic use , Biological Products/pharmacology , Drug Resistance , Etanercept/therapeutic use , Glucocorticoids/therapeutic use , Infliximab/therapeutic use , Off-Label Use , Sarcoidosis/immunology , Sarcoidosis/pathology , Skin Diseases/immunology , Skin Diseases/pathology , Treatment Outcome
12.
Dermatol Surg ; 45(2): 210-215, 2019 02.
Article in English | MEDLINE | ID: mdl-30608286

ABSTRACT

BACKGROUND: Internal eye shields are designed for use in periorbital procedures, but their use in Mohs micrographic surgery (MMS) of the eyelids has rarely been reported in the literature. OBJECTIVE: The authors aim to discuss different types of internal eye shields as well as their indication, proper use, and potential complications. MATERIALS AND METHODS: The authors performed a literature search on PubMed with the keywords "internal eye shield," "corneal shield," "scleral shield," and "periorbital Mohs micrographic surgery" with no restriction on publication time frame due to the scarcity of relevant literature. RESULTS: Experts seem to agree that use of eye shield for MMS of the eyelids is a reasonable measure to undertake to prevent operative injuries. Although either plastic or stainless steel eye shield can be used, plastic eye shields are often preferred and recommended in procedures where electrosurgical devices need to be used. CONCLUSION: Although the authors recommend the use of internal eye shields for MMS of the eyelids for preventing operative injuries, this recommendation (Grade C) is based on very limited evidence (Level 5). More research and higher-powered studies are needed for conclusive evidence and to establish clear guidelines for providers.


Subject(s)
Eye Injuries/prevention & control , Eye Protective Devices , Eyelid Neoplasms/surgery , Facial Neoplasms/surgery , Mohs Surgery , Ophthalmologic Surgical Procedures , Equipment Design , Eye Injuries/etiology , Humans , Postoperative Complications/prevention & control
14.
Int J Dermatol ; 58(2): 151-158, 2019 Feb.
Article in English | MEDLINE | ID: mdl-29777543

ABSTRACT

Acquired digital fibrokeratoma (ADFK) is a rare, benign, fibrous tumor that most often occurs on fingers. It may resemble a rudimentary supernumerary digit and is often misdiagnosed as another common benign condition, such as common wart. It is typically asymptomatic and occurs as a solitary nodule less than 1 cm in diameter. Oftentimes ADFK shares clinical and/or histologic resemblance with other benign and malignant cutaneous conditions so it is crucial that careful examination is undertaken. In this article, we will discuss the clinical presentation, epidemiology, etiology, dermoscopic and histologic findings, management, and differential diagnoses for ADFK, with the hope that this review will facilitate timely diagnosis and management for this distinct condition.


Subject(s)
Fibroma/diagnostic imaging , Hand Dermatoses/diagnostic imaging , Keratosis/diagnostic imaging , Skin Neoplasms/diagnostic imaging , Dermoscopy , Diagnosis, Differential , Fibroma/epidemiology , Fibroma/pathology , Fingers , Hand Dermatoses/epidemiology , Hand Dermatoses/pathology , Humans , Keratosis/epidemiology , Keratosis/pathology , Skin Neoplasms/epidemiology , Skin Neoplasms/pathology
16.
Cureus ; 10(10): e3429, 2018 Oct 09.
Article in English | MEDLINE | ID: mdl-30555754

ABSTRACT

Nasogastric (NG) intubation is a common yet one of the most uncomfortable minor procedures done in children and adults alike. A variety of analgesics, such as ketamine, lidocaine, and nitrous oxide, have been shown to reduce pain in various minor pediatric procedures. This retrospective study explores how often various pain management practices are used, either alone or in combination. The study examines NG intubation in pediatrics in one pediatric academic health system. The comfort measures used include analgesics, distraction, child life, swaddling, nitrous oxide, and others. Pharmacological intervention (analgesics) and distraction were most frequently used. Larger randomized studies should be conducted to determine the best practices for comfort measures for NG intubation in order to achieve maximal pain and anxiety reduction for children of various ages.

17.
Cureus ; 10(10): e3401, 2018 Oct 02.
Article in English | MEDLINE | ID: mdl-30533335

ABSTRACT

Basal cell carcinoma is the most common malignancy worldwide, but it very rarely metastasizes. Perineural invasion in basal cell carcinoma has been well documented in the literature, but evidence of intravascular invasion has rarely been reported. We describe a rare case of metatypical basal cell carcinoma with intravascular invasion and discuss the clinical management associated with this presentation. The patient was successfully treated with two stages of Mohs micrographic surgery.

SELECTION OF CITATIONS
SEARCH DETAIL
...